Logo image of MYTE

MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis

NYSE:MYTE - New York Stock Exchange, Inc. - US55406W1036 - ADR - Currency: USD

11.8341  -0.55 (-4.41%)

Fundamental Rating

4

MYTE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. MYTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYTE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MYTE had positive earnings in the past year.
In the past year MYTE had a positive cash flow from operations.
In the past 5 years MYTE reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MYTE reported negative operating cash flow in multiple years.
MYTE Yearly Net Income VS EBIT VS OCF VS FCFMYTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

MYTE has a Return On Assets of -5.41%. This is in the lower half of the industry: MYTE underperforms 69.23% of its industry peers.
MYTE has a Return On Equity of -8.76%. This is comparable to the rest of the industry: MYTE outperforms 44.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.40%, MYTE is doing worse than 63.25% of the companies in the same industry.
Industry RankSector Rank
ROA -5.41%
ROE -8.76%
ROIC 0.4%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
MYTE Yearly ROA, ROE, ROICMYTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

Looking at the Operating Margin, with a value of 0.29%, MYTE is doing worse than 63.25% of the companies in the same industry.
The Gross Margin of MYTE (46.77%) is better than 72.65% of its industry peers.
MYTE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.29%
PM (TTM) N/A
GM 46.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
MYTE Yearly Profit, Operating, Gross MarginsMYTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MYTE is destroying value.
MYTE has more shares outstanding than it did 1 year ago.
MYTE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MYTE has been reduced compared to a year ago.
MYTE Yearly Shares OutstandingMYTE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MYTE Yearly Total Debt VS Total AssetsMYTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.86 indicates that MYTE is not in any danger for bankruptcy at the moment.
MYTE has a Altman-Z score of 4.86. This is amongst the best in the industry. MYTE outperforms 86.32% of its industry peers.
MYTE has a debt to FCF ratio of 11.15. This is a negative value and a sign of low solvency as MYTE would need 11.15 years to pay back of all of its debts.
MYTE's Debt to FCF ratio of 11.15 is in line compared to the rest of the industry. MYTE outperforms 50.43% of its industry peers.
MYTE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
MYTE has a better Debt to Equity ratio (0.16) than 64.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 11.15
Altman-Z 4.86
ROIC/WACC0.06
WACC6.87%
MYTE Yearly LT Debt VS Equity VS FCFMYTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.95 indicates that MYTE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.95, MYTE belongs to the top of the industry, outperforming 80.34% of the companies in the same industry.
MYTE has a Quick Ratio of 1.95. This is a bad value and indicates that MYTE is not financially healthy enough and could expect problems in meeting its short term obligations.
MYTE has a worse Quick ratio (0.26) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 0.26
MYTE Yearly Current Assets VS Current LiabilitesMYTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.67% over the past year.
MYTE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.51%.
Measured over the past years, MYTE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.
EPS 1Y (TTM)41.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)9.51%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%7.41%

3.2 Future

Based on estimates for the next years, MYTE will show a very strong growth in Earnings Per Share. The EPS will grow by 54.63% on average per year.
MYTE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.58% yearly.
EPS Next Y231.5%
EPS Next 2Y99.87%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year8.01%
Revenue Next 2Y8.86%
Revenue Next 3Y9.58%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYTE Yearly Revenue VS EstimatesMYTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 500M 1B 1.5B
MYTE Yearly EPS VS EstimatesMYTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 0.1 0.2 0.3 0.4 0.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 65.75, which means the current valuation is very expensive for MYTE.
MYTE's Price/Earnings is on the same level as the industry average.
MYTE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.39.
The Price/Forward Earnings ratio is 35.87, which means the current valuation is very expensive for MYTE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYTE is on the same level as its industry peers.
MYTE is valuated cheaply when we compare the Price/Forward Earnings ratio to 94.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 65.75
Fwd PE 35.87
MYTE Price Earnings VS Forward Price EarningsMYTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYTE is valued a bit more expensive than 65.81% of the companies in the same industry.
MYTE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 145.69
EV/EBITDA 49.5
MYTE Per share dataMYTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYTE's earnings are expected to grow with 54.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y99.87%
EPS Next 3Y54.63%

0

5. Dividend

5.1 Amount

No dividends for MYTE!.
Industry RankSector Rank
Dividend Yield N/A

MYT NETHERLANDS PARENT BV

NYSE:MYTE (2/12/2025, 10:29:47 AM)

11.8341

-0.55 (-4.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)02-13 2025-02-13/bmo
Inst Owners17.99%
Inst Owner Change-99.96%
Ins Owners1.44%
Ins Owner ChangeN/A
Market Cap1.00B
Analysts74.55
Price Target7.16 (-39.5%)
Short Float %0.64%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)77.99%
Min EPS beat(2)-50.98%
Max EPS beat(2)206.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)-3.03%
Revenue beat(4)0
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)-0.69%
Revenue beat(8)2
Avg Revenue beat(8)-1.82%
Revenue beat(12)3
Avg Revenue beat(12)-2%
Revenue beat(16)6
Avg Revenue beat(16)-0.85%
PT rev (1m)9.35%
PT rev (3m)50.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.63%
EPS NY rev (1m)1.3%
EPS NY rev (3m)82.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 65.75
Fwd PE 35.87
P/S 1.14
P/FCF 145.69
P/OCF 58.35
P/B 2.33
P/tB 3.71
EV/EBITDA 49.5
EPS(TTM)0.18
EY1.52%
EPS(NY)0.33
Fwd EY2.79%
FCF(TTM)0.08
FCFY0.69%
OCF(TTM)0.2
OCFY1.71%
SpS10.4
BVpS5.08
TBVpS3.19
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.41%
ROE -8.76%
ROCE 0.53%
ROIC 0.4%
ROICexc 0.4%
ROICexgc 0.6%
OM 0.29%
PM (TTM) N/A
GM 46.77%
FCFM 0.78%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score4
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 11.15
Debt/EBITDA 3.06
Cap/Depr 52.8%
Cap/Sales 1.17%
Interest Coverage 0.44
Cash Conversion 78.01%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 0.26
Altman-Z 4.86
F-Score4
WACC6.87%
ROIC/WACC0.06
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y231.5%
EPS Next 2Y99.87%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)9.51%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%7.41%
Revenue Next Year8.01%
Revenue Next 2Y8.86%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y120.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.71%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y-83.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.2%
OCF growth 3YN/A
OCF growth 5Y33.41%